Tibi Sahulat
- About Alpha-1 Antitrypsin Deficiency Types of Alpha-1 Antitrypsin Deficiency Symptoms of Alpha-1 Antitrypsin Deficiency Diagnoses of Alpha-1 Antitrypsin Deficiency What Alpha-1 Antitrypsin Deficiency causes How Alpha-1 Antitrypsin Deficiency is treated How to live with Alpha-1 Antitrypsin Deficiency and self-help
- Home List of All Diseases
- A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Alpha-1 Antitrypsin Deficiency (AATD) is an uncommon hereditary disorder caused by a lack of the protein alpha-1 antitrypsin (AAT). AAT is produced in the liver and assists in protecting the lungs from harm due to inflammatory enzymes. When there is not enough AAT, the lungs can become damaged, leading to various health issues. AATD can cause a range of symptoms, including breathlessness, wheezing, and coughing. It can also result in more serious complications, such as emphysema, bronchiectasis, and lung cancer. Individuals with AATD may also be more prone to getting infections in their lungs, for example pneumonia. AATD is normally diagnosed through a blood test. Treatment usually involves medications to help reduce inflammation and open up the airways, as well as lifestyle changes such as quitting smoking and avoiding exposure to pollutants. In some cases, a liver transplant may be necessary to supply the body with enough AAT. AATD is a severe condition, yet with proper treatment, people with the disorder can live long and healthy lives.
- PiZZ: The most common type of Alpha-1 Antitrypsin Deficiency. It is caused by a mutation in the SERPINA1 gene, which results in the production of an abnormal form of the alpha-1 antitrypsin protein.
- PiSZ: A rare type of Alpha-1 Antitrypsin Deficiency caused by a mutation in the SERPINA1 gene, which results in the production of an abnormal form of the alpha-1 antitrypsin protein.
- PiMZ: A rare type of Alpha-1 Antitrypsin Deficiency caused by a mutation in the SERPINA1 gene, which results in the production of an abnormal form of the alpha-1 antitrypsin protein.
- PiZnull: A rare type of Alpha-1 Antitrypsin Deficiency caused by a mutation in the SERPINA1 gene, which results in the complete absence of alpha-1 antitrypsin protein.
- PiZ-variant: A rare type of Alpha-1 Antitrypsin Deficiency caused by a mutation in the SERPINA1 gene, which results in the production of an abnormal form of the alpha-1 antitrypsin protein.
- Shortness of breath
- Wheezing
- Coughing
- Fatigue
- Chest pain
- Recurrent respiratory infections
- Bluish discoloration of the skin (cyanosis)
- Abnormal lung sounds
- Rapid heartbeat
- Abnormal enlargement of the liver (hepatomegaly)
- Abnormal enlargement of the spleen (splenomegaly)
- Joint pain
- Skin rashes
- Poor growth in children
- Easy bruising
- Yellowing of the skin and eyes (jaundice)
- Abnormal accumulation of fluid in the abdomen (ascites)
- Abnormal accumulation of fluid in the lungs (pleural effusion)
- Abnormal accumulation of fluid in the legs (edema)
- Abnormal accumulation of fat in the liver (steatosis)
AATD is identified by a blood test that gauges the amount of alpha-1 antitrypsin protein in the body. If the numbers are reduced, it is a sign of AATD. Other tests, such as a lung capacity test, may also be used to diagnose AATD. In certain cases, a liver biopsy may be carried out to confirm the diagnosis.
Alpha-1 Antitrypsin Deficiency is a hereditary illness that can cause severe lung and liver harm. In the lungs, it can cause emphysema, a state in which the air sacs of the lungs are harmed and respiration becomes arduous. In the liver, it can lead to cirrhosis, a condition in which the liver is scarred and unable to operate correctly.
Alpha-1 Antitrypsin Deficiency is generally treated with a mixture of drugs, changes in lifestyle, and supportive treatments. Augmentation therapy, which entails getting weekly injections of Alpha-1 Antitrypsin protein to make up for the protein lacking in the body, and anti-inflammatory medications, like corticosteroids, to minimize inflammation in the lungs, are some of the medications used to treat the condition. Additionally, avoiding smoking, keeping a healthy weight, eating a balanced diet, and exercising regularly are lifestyle modifications that can help lessen the symptoms. Furthermore, pulmonary rehabilitation and breathing exercises, which are supportive therapies, can help improve lung function and quality of life.
Follow your physician's instructions: Alpha-1 Antitrypsin Deficiency (AATD) is a severe condition and the most effective way to maintain your wellbeing is to follow your doctor's instructions. Ensure to attend all planned medical appointments and take any prescribed medicines as directed. Cease smoking: Smoking can worsen the symptoms of AATD, so if you are a smoker, quitting is essential. Converse with your doctor about ways to quit smoking and get assistance from family and friends. Exercise often: Exercise can help enhance your overall health, reduce your risk of complications, and improve your quality of life. Speak with your doctor about the most suitable type of exercise for you. Consume a healthy diet: Eating a healthy diet can help you sustain a healthy weight, decrease your risk of complications, and enhance your overall health. Converse with a nutritionist about the best diet for you. Get sufficient rest: Getting enough rest is essential for managing AATD. Make sure to get at least 7-8 hours of sleep each night and take naps during the day if needed. Evade air pollutants: Air pollutants can worsen the symptoms of AATD, so it’s important to avoid them as much as possible. This includes avoiding smog, car exhaust, and other sources of air pollution. Remain hydrated: Staying hydrated is essential for managing AATD. Make sure to drink at least 8 glasses of water each day and talk to your doctor about any other fluids you should be drinking. Join a support system: AATD can be a difficult condition to manage, so it’s important to have support. Take into consideration joining a support group to connect with other people who understand what you’re going through.